|
US9394333B2
(en)
|
2008-12-02 |
2016-07-19 |
Wave Life Sciences Japan |
Method for the synthesis of phosphorus atom modified nucleic acids
|
|
MX342945B
(es)
|
2009-07-06 |
2016-10-18 |
Ontorii Inc * |
Profármacos de ácido nucleico novedosos y métodos de uso de los mismos.
|
|
DK2620428T3
(da)
|
2010-09-24 |
2019-07-01 |
Wave Life Sciences Ltd |
Asymmetrisk hjælpegruppe
|
|
US9605019B2
(en)
|
2011-07-19 |
2017-03-28 |
Wave Life Sciences Ltd. |
Methods for the synthesis of functionalized nucleic acids
|
|
KR20240148947A
(ko)
|
2012-07-13 |
2024-10-11 |
웨이브 라이프 사이언시스 리미티드 |
키랄 제어
|
|
SG11201500243WA
(en)
|
2012-07-13 |
2015-04-29 |
Shin Nippon Biomedical Lab Ltd |
Chiral nucleic acid adjuvant
|
|
SG11201500239VA
(en)
|
2012-07-13 |
2015-03-30 |
Wave Life Sciences Japan |
Asymmetric auxiliary group
|
|
US11162096B2
(en)
|
2013-10-14 |
2021-11-02 |
Ionis Pharmaceuticals, Inc |
Methods for modulating expression of C9ORF72 antisense transcript
|
|
EP3095460A4
(en)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
|
|
WO2015108047A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
|
|
WO2015108048A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
|
|
ES2917473T3
(es)
|
2014-01-16 |
2022-07-08 |
Wave Life Sciences Ltd |
Diseño quiral
|
|
CA2968336C
(en)
|
2014-12-17 |
2021-11-23 |
Proqr Therapeutics Ii B.V. |
Construct for site directed editing of an adenosine nucleotide in target rna
|
|
US10793855B2
(en)
*
|
2015-01-06 |
2020-10-06 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating expression of C9ORF72 antisense transcript
|
|
WO2016167780A1
(en)
|
2015-04-16 |
2016-10-20 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating expression of c9orf72 antisense transcript
|
|
CN108025089A
(zh)
|
2015-07-22 |
2018-05-11 |
波涛生命科学有限公司 |
寡核苷酸组合物及其方法
|
|
WO2017067970A1
(en)
|
2015-10-22 |
2017-04-27 |
Roche Innovation Center Copenhagen A/S |
In vitro toxicity screening assay
|
|
US11267843B2
(en)
*
|
2016-03-18 |
2022-03-08 |
Roche Innovation Center Copenhagen A/S |
Stereodefining L-monomers
|
|
CN109477108A
(zh)
|
2016-05-04 |
2019-03-15 |
波涛生命科学有限公司 |
寡核苷酸组合物和其方法
|
|
US11479818B2
(en)
*
|
2016-06-17 |
2022-10-25 |
Hoffmann-La Roche Inc. |
In vitro nephrotoxicity screening assay
|
|
EP3472346B1
(en)
|
2016-06-17 |
2023-01-18 |
F. Hoffmann-La Roche AG |
Papd5 and papd7 inhibitors for treating a hepatitis b infection
|
|
WO2017216340A1
(en)
*
|
2016-06-17 |
2017-12-21 |
F. Hoffmann-La Roche Ag |
In vitro nephrotoxicity screening assay
|
|
CN109477103A
(zh)
|
2016-06-22 |
2019-03-15 |
ProQR治疗上市公司Ⅱ |
单链rna-编辑寡核苷酸
|
|
EP3507366B1
(en)
|
2016-09-01 |
2020-10-07 |
ProQR Therapeutics II B.V. |
Chemically modified single-stranded rna-editing oligonucleotides
|
|
CN114621302A
(zh)
*
|
2016-11-14 |
2022-06-14 |
学校法人东京理科大学 |
聚合性化合物、化合物、及硼烷磷酸酯低聚物的制造方法
|
|
JP7296882B2
(ja)
|
2016-11-23 |
2023-06-23 |
ウェイブ ライフ サイエンシズ リミテッド |
ホスホラミダイト及びオリゴヌクレオチド合成のための組成物及び方法
|
|
WO2018130583A1
(en)
*
|
2017-01-13 |
2018-07-19 |
Roche Innovation Center Copenhagen A/S |
Antisense oligonucleotides for modulating nfkb1 expression
|
|
WO2018130585A1
(en)
*
|
2017-01-13 |
2018-07-19 |
Roche Innovation Center Copenhagen A/S |
Antisense oligonucleotides for modulating relb expression
|
|
EP3571300A1
(en)
|
2017-01-19 |
2019-11-27 |
ProQR Therapeutics II B.V. |
Oligonucleotide complexes for use in rna editing
|
|
EP3694995A1
(en)
|
2017-10-13 |
2020-08-19 |
Roche Innovation Center Copenhagen A/S |
Methods for identifying improved stereodefined phosphorothioate oligonucleotide variants of antisense oligonucleotides utilising sub-libraries of partially stereodefined oligonucleotides
|
|
TW202424191A
(zh)
*
|
2017-10-16 |
2024-06-16 |
瑞士商赫孚孟拉羅股份公司 |
用於降低PAPD5及PAPD7 mRNA以治療B型肝炎感染之核酸分子
|
|
HRP20250804T1
(hr)
|
2017-12-01 |
2025-09-12 |
The Texas A&M University System |
Antisense liječenje angelmanovog sindroma
|
|
US20200339982A1
(en)
*
|
2017-12-22 |
2020-10-29 |
Roche Innovation Center Copenhagen A/S |
Oligonucleotides comprising a phosphorodithioate internucleoside linkage
|
|
KR20200104302A
(ko)
*
|
2017-12-22 |
2020-09-03 |
로슈 이노베이션 센터 코펜하겐 에이/에스 |
신규 티오포스포르아미다이트
|
|
KR20200104347A
(ko)
*
|
2017-12-22 |
2020-09-03 |
로슈 이노베이션 센터 코펜하겐 에이/에스 |
포스포로디티오에이트 인터뉴클레오시드 연결을 포함하는 갭머 올리고뉴클레오티드
|
|
MX2020007433A
(es)
|
2018-01-12 |
2020-09-14 |
Bristol Myers Squibb Co |
Oligonucleotidos antisentido que actuan sobre alfa-sinucleina, y usos de estos.
|
|
EA202091693A1
(ru)
|
2018-01-12 |
2021-04-14 |
Бристол-Маерс Сквибб Компани |
Антисмысловые олигонуклеотиды, целенаправленно воздействующие на альфа-синуклеин, и их применения
|
|
EP3774824A1
(en)
|
2018-04-13 |
2021-02-17 |
Bristol-Myers Squibb Company |
Novel phosphorous (v)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (v) compounds
|
|
GB201808146D0
(en)
|
2018-05-18 |
2018-07-11 |
Proqr Therapeutics Ii Bv |
Stereospecific Linkages in RNA Editing Oligonucleotides
|
|
PE20220013A1
(es)
|
2018-07-03 |
2022-01-11 |
Hoffmann La Roche |
Oligonucleotidos para modular la expresion de tau
|
|
CN112469827B
(zh)
*
|
2018-07-04 |
2024-05-24 |
学校法人爱知医科大学 |
控制Tau的剪接的反义寡核苷酸及其用途
|
|
CN113490742A
(zh)
*
|
2019-02-20 |
2021-10-08 |
罗氏创新中心哥本哈根有限公司 |
膦酰基乙酸酯缺口聚物寡核苷酸
|
|
US11466274B2
(en)
|
2019-05-31 |
2022-10-11 |
Aligos Therapeutics, Inc. |
Modified gapmer oligonucleotides and methods of use
|
|
WO2021146391A1
(en)
|
2020-01-16 |
2021-07-22 |
Bristol-Myers Squibb Company |
Reagents and their use for modular enantiodivergent synthesis of c–p bonds
|
|
AU2022242781A1
(en)
*
|
2021-03-26 |
2023-10-26 |
Neumirna Therapeutics Aps |
Microrna-27b inhibitors
|
|
CN120187734A
(zh)
|
2022-09-19 |
2025-06-20 |
百时美施贵宝公司 |
新的基于磷(v)的试剂、其制备方法以及其在制备立体定义的有机磷(v)化合物中的用途
|